Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2021.229 | Survey of treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor |
Dr. NG Danny Siu Chun 吳兆駿 |
| 2021.619 | Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study |
Dr. NG Danny Siu Chun 吳兆駿 |
| 2021.583 | Accuracy and validity of non-invasive cardiac output measurements in critically ill neonates by electrical velocimetry in comparison with transthoracic echocardiography |
Dr. NG Chun Hong 伍俊康 |
| 2021.628 | Artificial Intelligence in suggesting optimized radiotherapy treatment techniques for non-small cell lung cancer (NSCLC) | Ms. NG Ching Fung |
| 2013.282 | A Phase III, Randomized Clinical Trial to Study the Safety and Efficacy of MK-906 (Finasteride) and Tamsulosin Administered Either Alone or Concomitantly in Patients with Benign Prostatic Hyperplasia (BPH) | Professor Ng Chi-Fai |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2012.105 | ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC | Prof. NG Chi Fai |
| 2014.214 | A longitudinal study on the outcome of male voiding dysfunction in Hong Kong Chinese Male | Prof. NG Chi Fai |
| 2014.090 | A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Treated with Enzalutamide Who Are at Potential Increased Risk of Seizure | Prof. NG Chi Fai |
| 2010.392 | A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi | Prof Ng Chi Fai |
| 2009.620 | Strategies To Prevent Renal Trauma | Prof. Ng Chi Fai |
| 2010.507 | The role of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia. | Prof. Ng Chi Fai |
| 2011.375 | A prospective randomized double-blinded placebo controlled study on the effects of shockwave therapy in patients suffered erectile dysfunction | Prof. Ng Chi Fai |
| 2008.062 | A Prospective Study to Investigate the Effects of Different Shockwave Delivery Rates in Extracorporeal Shockwave Lithotripsy in Patients Suffer form Renal Calculi | Prof. Ng Chi Fai |
| 2009.528 | A Phase 2B, Randomized, Double-blind, Placebo-Controlled, Dose Ranging Study Evaluating the Efficacy and Safety of Tanezumab for the Treatment of Moderate to Severe Pain Associated with Interstitial Cystitis / Painful Bladder Syndrome (IC/PBS) | Dr. Ng Chi Fai |
| 2010.125 | Study on Comparison of the clinical outcomes of extracorporeal shock wave lithotripsy for lower ureteric stone treated at different patient position | Prof. Ng Chi Fai |
| 2014.096 | A prospective study to investigate the effect of stepwise voltage escalation on treatment outcome in extracorporeal shockwave lithotripsy of renal calculi | Prof. Ng Chi Fai |
| 2009.333 | The impact of 60 verse 120 shock wave per minute on treatment outcome, renal injury and patients | Prof. Ng Chi Fai |
| 2010.465 | A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Chemotherapy-Na_ve Metastatic Castration-Resistant Prostate Cancer | Professor Ng Chi Fai |
| 2013.493 | A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence | Prof Ng Chi Fai |
| 2012.399 | Health Exhibition Health Check Survey | Prof. Ng Chi Fai |
| 2008.324 | A Randomized, Open Label, Multi-Center Phase II Study to Compare Bevacizumab Plus RAD001 Versus Interferon Alfa-2a Plus Bevacizumab for the First-line Treatment of Patients with Metastatic Clear Cell Carcinoma of the Kidney | Prof Ng Chi Fai |
| 2013.494 | PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | Prof. NG Chi Fai |
| 2012.316 | The pattern of presentation of Chinese diagnosed with prostate cancer | Prof Ng Chi Fai |
| 2010.577 | Prospective study of the effect of androgen deprivation therapy (ADT) in male patients suffered prostate cancer in Chinese Population | Prof. NG Chi Fai |
| 2010.494 | A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy | Prof. Ng Chi Fai |
| 2024.114 | Surveys to investigate injection site complications and pain related to androgen deprivation therapies in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2021.650 | Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study |
Prof. NG Chi Fai 吳志輝 |
| 2023.180 | Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long-Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Metastatic Prostate Cancer in Hong Kong. |
Prof. NG Chi Fai 吳志輝 |
| 2022.051 | A territory-wide retrospective study comparing the effects of different types of androgen deprivation therapy on cardiovascular disease of prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.645 | To linguistically and psychometrically validate the Hong Kong Chinese version of the BPH 3-item questionnaire | Prof. NG Chi Fai |
| 2023.085 | Association between nephrolithiasis and future cardiovascular events: a population-based analysis of patients utilizing public health systems in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2022.049 | A prospective assessment of the perioperative parameter and treatment outcomes of surgical treatment for benign prostate hyperplasia in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2022.046 | To understand the role of spermine on prostate cancer and its potential therapeutic application |
Prof. NG Chi Fai 吳志輝 |
| 2023.084 | Clinical Characteristics, Anticholinergic Burden, Treatment Patterns, and Drug Persistence in Patients with Overactive Bladder in Hong Kong: A Real-World Observational Study |
Prof. NG Chi Fai 吳志輝 |
| 2023.509 | To investigate the effect of multidisciplinary care approach on cardiovascular risk modification in prostate cancer patients receiving androgen deprivation therapy |
Prof. NG Chi Fai Chi Fai NG |
| 2021.484 | Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) |
Prof. NG Chi Fai 吳志輝 |
| 2022.560 | To study the effect of baseline testosterone level on prognosis in Asian patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2021.675 | Development of luminescent nanobiosensor for bladder cancer miRNA detection |
Prof. NG Chi Fai 吳志輝 |
| 2021.684 | A prospective assessment of the perioperative parameter and treatment outcomes of urinary calculi in Hong Kong |
Prof . NG Chi Fai 吳志輝 |
| 2021.687 | Surgical PRODUCT SURVEILLANCE REGISTRY (PSR) PLATFORM BASE & Medtronic Hugo™ RAS System General Surveillance in Hong Kong Product Surveillance Registry (PSR) Platform Analysis Plan |
Prof. NG Chi Fai 吳志輝 |
| 2022.244 | The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2023.589 | Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial | Prof. NG Chi Fai |
| 2021.652 | TFL vs Ho:YAG – A prospective study to compare the effectiveness of Thulium Fiber laser and Holmium YAG laser for ureteroscopic lithotripsy |
Prof. NG Chi Fai 吳志輝 |
| 2021.506 | To investigate the effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy | Prof. NG Chi Fai |
| 2022.394 | Elucidating the functional role of exosomal protein LRG1 and its clinical implication in castration-resistant prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2022.301 | A study to evaluate patient and physician benefit/ risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: a discrete choice experiment |
Prof NG Chi Fai 吳志輝 |
| 2022.158 | The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients |
Prof. NG Chi Fai 吳志輝 |
| 2023.583 | A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma | Prof. NG Chi Fai |
| 2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
Page 83 of 254.